Journal article
Patterns of care and outcomes in small cell carcinoma of the prostate: A national cancer database analysis
The Prostate, v 79(12), pp 1457-1461
Sep 2019
PMID: 31294484
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Small cell carcinoma (SCC) of the prostate is a rare, aggressive disease. Evidence is limited; however, the current standard of care is chemotherapy. The benefit of local treatment modalities is unknown.
We queried the National Cancer Database identifying all SCC/neuroendocrine cases of the prostate, excluding those with unknown nodal or metastatic status, unknown treatment, or those not receiving chemotherapy. Overall survival (OS) was calculated using Kaplan-Meier curves. Multivariable Cox proportional hazards model was used to identify factors associated with survival. A further subgroup analysis was performed on the utility of local therapy on survival in the nonmetastatic setting.
Our final cohort included 657 patients with a median age of 68. Most patients had positive lymph nodes (60.1%) and metastatic disease (70.0%). Median survival was 12 months (95% confidence interval [95% CI], 11.1-13.3 months) with a median follow-up of 11.8 months. Metastatic disease, age greater than or equal to 70, omission of androgen deprivation therapy (ADT), and lower income (P < .05 for all) were all associated with reduced OS. Patients with prostate-specific antigen (PSA) greater than or equal to 33 ng/mL and those receiving ADT had better survival (P < .05). Those with nonmetastatic disease were more likely to undergo prostatectomy and/or prostatic/pelvic radiation (P < .0001). Prostatic/pelvic radiation in the nonmetastatic setting was associated with longer survival (P = .02). Though well powered, our study is limited by the selection bias inherent to all observational studies, despite the statistical methods utilized to reduce this effect.
Although chemotherapy is the mainstay of treatment, radiation to the prostate/pelvis may be beneficial in the nonmetastatic setting. In addition to chemotherapy, ADT may benefit patients with an elevated PSA.
Metrics
Details
- Title
- Patterns of care and outcomes in small cell carcinoma of the prostate: A national cancer database analysis
- Creators
- April L Metzger - Allegheny Health NetworkStephen Abel - Allegheny Health NetworkRodney E Wegner - Allegheny Health NetworkRussell Fuhrer - Allegheny Health NetworkShifeng Mao - Allegheny Health NetworkRalph Miller - Allegheny Health NetworkSushil Beriwal - University of Pittsburgh Medical CenterZachary D Horne - Allegheny Health Network
- Publication Details
- The Prostate, v 79(12), pp 1457-1461
- Publisher
- Wiley
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine); General Internal Medicine
- Web of Science ID
- WOS:000477445400001
- Scopus ID
- 2-s2.0-85068798938
- Other Identifier
- 991021897389004721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Endocrinology & Metabolism
- Urology & Nephrology